Presentation is loading. Please wait.

Presentation is loading. Please wait.

Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years:

Published byAngelika Ursler Modified over 6 years ago

Similar presentations

Presentation on theme: "Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years:"— Presentation transcript:

1 Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study  F. Ma, J. Yang, G. Kang, Q. Sun, P. Lu, Y. Zhao, Z. Wang, J. Luo, Z. Wang  Clinical Microbiology and Infection  Volume 22, Issue 9, Pages 811.e9-811.e15 (September 2016) DOI: /j.cmi Copyright © Terms and Conditions

2 Fig. 1 Disposition of participants. HA-L, live attenuated hepatitis A vaccine; HA-I, inactivated hepatitis A vaccine; ECLIA, electrochemiluminescence immunoassay; Anti-HAV IgG, antibodies against hepatitis A virus IgG. Clinical Microbiology and Infection  , 811.e9-811.e15DOI: ( /j.cmi ) Copyright © Terms and Conditions

3 Fig. 2 Vaccine hepatitis A antigen (HAAg) -positive rates in stool samples from participants given live attenuated hepatitis A vaccine (HA-L). Clinical Microbiology and Infection  , 811.e9-811.e15DOI: ( /j.cmi ) Copyright © Terms and Conditions

Download ppt "Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years:"

Similar presentations

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.
Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4–24 years in Turkey  M. Cevik, U. Beyazova, A.L. Aral, A. Duyan.

Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4–24 years in Turkey  M. Cevik, U. Beyazova, A.L. Aral, A. Duyan.
Volume 50, Issue 4, Pages (April 2009)

Volume 50, Issue 4, Pages (April 2009)
R. Cavallo  Clinical Microbiology and Infection 

R. Cavallo  Clinical Microbiology and Infection 
Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013  J. Verschueren, L. Cnops,

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013  J. Verschueren, L. Cnops,
Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994  C. Ramière, L. Roche,

Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994  C. Ramière, L. Roche,
Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience  M.-C.

Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience  M.-C.
Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection  D.K.-H. Wong, J. Fung, C.-K. Lee, W.-K.

Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection  D.K.-H. Wong, J. Fung, C.-K. Lee, W.-K.
Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.
Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care  S. Chevaliez,

Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care  S. Chevaliez,
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 

D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.

Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Migrant health—a cause for concern?

Migrant health—a cause for concern?
The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional.

The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional.
The relationship between tumour necrosis factor-α gene polymorphism and susceptibility and clearance of the persistent hepatitis B virus infection in.

The relationship between tumour necrosis factor-α gene polymorphism and susceptibility and clearance of the persistent hepatitis B virus infection in.
Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort study  P. Turner, C.

Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort study  P. Turner, C.
The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional.

The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional.
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 

Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection

Virological tools to diagnose and monitor hepatitis C virus infection
Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children  N. Agrinier, M. Le Maréchal,

Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children  N. Agrinier, M. Le Maréchal,

Similar presentations

Ads by Google